FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and biotechnology and represents a therapeutic antimalaria drug containing an antimalaria agent and excipients differing by the fact that it additionally contains a biomass of the Bacillus subtilis probiotic strains in the amount of CFU not less than 1×108 cell/tablet (dose) with the ingredients in the preparation taken in certain proportion, wt %.
EFFECT: invention provides antiprotozoal action with probiotic effect.
7 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIMALARIAL SYNERGISTIC COMPOSITION CONTAINING BENFLUMETHOL | 1993 |
|
RU2118158C1 |
| ANTIBIOTIC RESISTANT THERAPEUTIC BIOLOGICAL PRODUCT FOR BACTERIAL AND MYCOTIC INFECTIONS | 2010 |
|
RU2444366C1 |
| METHOD OF TREATING MALARIA USING A THERAPEUTIC COMBINATION OF TELOMERASE INHIBITORS (IIMATINIB MESILATE) AND ARTEMETHER | 2019 |
|
RU2722981C1 |
| NEW PROBIOTIC BASED ON A CONSORTIUM OF SPORE-FORMING BACTERIA FOR AQUACULTURE AND ANIMALS AND A METHOD OF ITS PRODUCTION | 2022 |
|
RU2799554C1 |
| PROBIOTIC FEED ADDITIVE FOR AGRICULTURAL ANIMALS AND BIRDS | 2016 |
|
RU2654875C2 |
| PROBIOTIC PREPARATION FOR VIRAL AND BACTERIAL INFECTIONS TOXISPORIN, METHOD FOR PREPARING IT, BACILLUS LICHENIFORMIS BACTERIAL STRAIN USED AS INGREDIENT OF PROBIOTIC PREPARATION | 2011 |
|
RU2471864C1 |
| COMBINED PROBIOTIC FOR AQUACULTURE BASED ON SPORE-FORMING BACTERIA OF THE GENUS BACILLUS AND A METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2768281C1 |
| CELL-FREE CULTURE LIQUID ON THE BASIS OF THE BACILLUS SUBTILIS, PRESERVING AGENT FOR SILAGE AND POLYFUNCTIONAL AGENT FOR PLANTS WITH FUNGICIDAL, BACTERICIDAL AND GROWTH PROMOTION PROPERTIES | 2017 |
|
RU2665547C1 |
| ACELLULAR PROBIOTIC BASED BIOLOGICALLY ACTIVE COMPLEX, FODDER COMPOSITION CONTAINING SUCH COMPLEX, METHOD FOR FARM ANIMALS AND POULTRY FEEDING | 2013 |
|
RU2538116C2 |
| METHOD OF FEEDING POULTRY WITH THE INTRODUCTION OF AN ADDITIVE BASED ON MICROORGANISMS OF THE GENUS BACILLUS INTO THE FEED | 2020 |
|
RU2762200C1 |
